AbbVie Inc. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains

Realty Income Corp

Change company Symbol lookup

Select an option...

O Realty Income Corp

DMO Western Asset Mortgage Opportunity Fund Inc

TEX Terex Corp

JEPI JPMorgan Equity Premium Income ETF

SPYD SPDR® Portfolio S&P 500 High Dividend ETF

AAPL Apple Inc

VYM Vanguard High Dividend Yield Index Fund ETF Shares

DGRO iShares Core Dividend Growth ETF

DIVO Amplify CWP Enhanced Dividend Income ETF

SCHD Schwab U.S. Dividend Equity ETF™

Real Estate : Equity Real Estate Investment Trusts (REITs) | Large Cap Blend

Company profile

Realty Income Corporation is a real estate investment trust. The Company is engaged in acquiring and managing single-unit freestanding commercial properties under a long-term net lease agreement with its commercial clients. The Company owns and operates diversified portfolio of over 11,400 commercial properties. The Company’s properties are leased to over 1,100 different clients who operate in approximately 72 separate industries throughout all 50 states, as well as Puerto Rico, the United Kingdom and Spain. Its properties are leased to retail and industrial clients that have a service, non-discretionary and/or low-price-point component to their business. The Company’s property types include retail, industrial, and agriculture.

AbbVie Inc. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains

4:33 pm ET November 14, 2022 (MarketWatch) Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of AbbVie Inc. (ABBV) rose 1.05% to $151.74 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.89% to 3,957.25 and Dow Jones Industrial Average falling 0.63% to 33,536.70. This was the stock's third consecutive day of gains. AbbVie Inc. closed $24.17 below its 52-week high ($175.91), which the company reached on April 8th.

The stock underperformed when compared to some of its competitors Monday, as Pfizer Inc. (PFE) rose 3.45% to $49.24, Eli Lilly & Co. (LLY) rose 1.35% to $356.06, and AstraZeneca PLC ADR (AZN.LN) rose 1.82% to $63.91. Trading volume (7.0 M) eclipsed its 50-day average volume of 5.6 M.

Data source: Dow Jones Market Data, FactSet. Data compiled November 14, 2022.

(END) Dow Jones Newswires

November 14, 2022 16:33 ET (21:33 GMT)